{
    "nctId": "NCT02809729",
    "briefTitle": "Antibiotic Prophylaxis in Oncological Surgery of Breast",
    "officialTitle": "Antibiotic Prophylaxis in Oncological Surgery of Breast: Randomized Clinical Trial",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Neoplasms, Breast-Conserving Surgery, Wound Infection, Antibiotic Prophylaxis",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 124,
    "primaryOutcomeMeasure": "surgical site infection in oncologic breast surgery",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* female patients who will undergo breast surgery for cancer evil, between 20 and 75 years, without any restriction as to ethnicity, education or social class;\n\nExclusion Criteria:\n\n* Patients with BMI greater than 30 kgm 2;\n* Patients undergoing neoadjuvant chemotherapy;\n* Patients that will undergo immediate breast reconstruction procedures;\n* Patients suffering from diabetes mellitus insulin-dependent;\n* Patients classified as ASA III or higher\n* Patients that postoperative antibiotic therapy have indication by another\n\nclinical complication (cystitis, pneumonia, etc.);\n\n-Patients to withdraw informed consent at any stage of the study;",
    "sex": "FEMALE",
    "minimumAge": "30 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}